GAIN THERAPEUTICS, INC Operating Lease Right-of-Use Assets
GAIN THERAPEUTICS, INC (GANX) had Operating Lease Right-of-Use Assets of $266.86 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-11
- 2026-06-30: Operating Lease, Right-of-Use Asset $266.86K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $300.58K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $334.09K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $184.42K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $266.86K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $300.58K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $334.09K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $184.42K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $233.20K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $183.66K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $219.72K 10-K · filed 2026-03-26 |
| 2024-09-30 | $281.58K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $325.88K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $384.15K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $459.21K 10-K · filed 2025-03-27 |
| 2023-09-30 | $490.76K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $559.77K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $609.88K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $659.93K 10-K · filed 2024-03-26 |
| 2022-09-30 | $670.26K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $745.88K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $831.23K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $901.04K 10-K · filed 2023-03-23 |
| 2021-09-30 | $747.53K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $812.41K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $499.02K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $523.08K 10-K · filed 2022-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |